Biologics Contract Development Market by Source, Product, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : August 2022 Pages : 158 Category: Pharma & Healthcare Report Code : HC0817417
The global Biologics Contract Development Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
The report exhibit detail coverage of Biologics Contract Development industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Biologics Contract Development Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Biologics Contract Development Market for 2017-2022.
Crystal Market Research envisions that the span of the Biologics Contract Development Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Biologics Contract Development in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Biologics Contract Development Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Biologics Contract Development Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Mexico, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- WuXi Biologics
- Abzena Ltd.
- Fujifilm Diosynth Biotechnologies
- KBI Biopharma
- AGC Biologics
- LakePharma
- Genscript Biotech Corporation
- Bionova Scientific
- SE Thermo Fisher (Patheon)
- Boehringer Ingelheim BioXcellence
- STC Biologics, Inc.
Market Classification
· Biologics Contract Development Market, By Source, Estimates and Forecast, 2017-2022 ($Million)
o Microbial
o Mammalian
o Others
· Biologics Contract Development Market, By Product, Estimates and Forecast, 2017-2022 ($Million)
o Cell Line Development
o Process Development
o Others
· Biologics Contract Development Market, By End User, Estimates and Forecast, 2017-2022 ($Million)
o Oncology
o Immunological Disorders
o Cardiovascular Disorders
o Hematological Disorders
o Others
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Biologics Contract Development Market, By Source
4.1. Introduction
4.2. Biologics Contract Development Market and Market Growth Rate By Source (2017-2022)
4.3. Microbial
4.3.1. Global Microbial Market and Growth Rate (2017-2022)
4.3. Mammalian
4.3.1. Global Mammalian Market and Growth Rate (2017-2022)
4.3. Others
4.3.1. Global Others Market and Growth Rate (2017-2022)
5. Biologics Contract Development Market, By Product
5.1. Introduction
5.2. Biologics Contract Development Market and Market Growth Rate By Product (2017-2022)
5.3. Cell Line Development
5.3.1. Global Cell Line Development Market and Growth Rate (2017-2022)
5.3. Process Development
5.3.1. Global Process Development Market and Growth Rate (2017-2022)
5.3. Others
5.3.1. Global Others Market and Growth Rate (2017-2022)
6. Biologics Contract Development Market, By End User
6.1. Introduction
6.2. Biologics Contract Development Market and Market Growth Rate By End User (2017-2022)
6.3. Oncology
6.3.1. Global Oncology Market and Growth Rate (2017-2022)
6.3. Immunological Disorders
6.3.1. Global Immunological Disorders Market and Growth Rate (2017-2022)
6.3. Cardiovascular Disorders
6.3.1. Global Cardiovascular Disorders Market and Growth Rate (2017-2022)
6.3. Hematological Disorders
6.3.1. Global Hematological Disorders Market and Growth Rate (2017-2022)
6.3. Others
6.3.1. Global Others Market and Growth Rate (2017-2022)
7. Biologics Contract Development Market, By Region
7.1. Introduction
7.2. Biologics Contract Development Market and Growth Rate By Regions
6.3. North America
7.3.1. North America Biologics Contract Development Market and Growth Rate (2017-2022))
7.3.2. North America Biologics Contract Development Market By Source (2017-2022)
7.3.2. North America Biologics Contract Development Market By Product (2017-2022)
7.3.2. North America Biologics Contract Development Market By End User (2017-2022)
7.3.4. North America Biologics Contract Development Market By Country (2017-2022)
7.3.5. United States
7.3.5.1.United States Biologics Contract Development Market and Growth Rate (2017-2022)
7.3.5.2.United States Biologics Contract Development Market By Source (2017-2022)
7.3.5.2.United States Biologics Contract Development Market By Product (2017-2022)
7.3.5.2.United States Biologics Contract Development Market By End User (2017-2022)
7.3.5. Canada
7.3.5.1.Canada Biologics Contract Development Market and Growth Rate (2017-2022)
7.3.5.2.Canada Biologics Contract Development Market By Source (2017-2022)
7.3.5.2.Canada Biologics Contract Development Market By Product (2017-2022)
7.3.5.2.Canada Biologics Contract Development Market By End User (2017-2022)
6.3. Europe
8.3.1. Europe Biologics Contract Development Market and Growth Rate (2017-2022))
8.3.2. Europe Biologics Contract Development Market By Source (2017-2022)
8.3.2. Europe Biologics Contract Development Market By Product (2017-2022)
8.3.2. Europe Biologics Contract Development Market By End User (2017-2022)
8.3.4. Europe Biologics Contract Development Market By Country (2017-2022)
8.3.5. Germany
8.3.5.1.Germany Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.Germany Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.Germany Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.Germany Biologics Contract Development Market By End User (2017-2022)
8.3.5. France
8.3.5.1.France Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.France Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.France Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.France Biologics Contract Development Market By End User (2017-2022)
8.3.5. UK
8.3.5.1.UK Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.UK Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.UK Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.UK Biologics Contract Development Market By End User (2017-2022)
8.3.5. Russia
8.3.5.1.Russia Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.Russia Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.Russia Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.Russia Biologics Contract Development Market By End User (2017-2022)
8.3.5. Italy
8.3.5.1.Italy Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.Italy Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.Italy Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.Italy Biologics Contract Development Market By End User (2017-2022)
8.3.5. Rest of Europe
8.3.5.1.Rest of Europe Biologics Contract Development Market and Growth Rate (2017-2022)
8.3.5.2.Rest of Europe Biologics Contract Development Market By Source (2017-2022)
8.3.5.2.Rest of Europe Biologics Contract Development Market By Product (2017-2022)
8.3.5.2.Rest of Europe Biologics Contract Development Market By End User (2017-2022)
6.3. Asia-Pacific
9.3.1. Asia-Pacific Biologics Contract Development Market and Growth Rate (2017-2022))
9.3.2. Asia-Pacific Biologics Contract Development Market By Source (2017-2022)
9.3.2. Asia-Pacific Biologics Contract Development Market By Product (2017-2022)
9.3.2. Asia-Pacific Biologics Contract Development Market By End User (2017-2022)
9.3.4. Asia-Pacific Biologics Contract Development Market By Country (2017-2022)
9.3.5. China
9.3.5.1.China Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.China Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.China Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.China Biologics Contract Development Market By End User (2017-2022)
9.3.5. Japan
9.3.5.1.Japan Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.Japan Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.Japan Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.Japan Biologics Contract Development Market By End User (2017-2022)
9.3.5. Korea
9.3.5.1.Korea Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.Korea Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.Korea Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.Korea Biologics Contract Development Market By End User (2017-2022)
9.3.5. India
9.3.5.1.India Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.India Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.India Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.India Biologics Contract Development Market By End User (2017-2022)
9.3.5. Southeast Asia
9.3.5.1.Southeast Asia Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.Southeast Asia Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.Southeast Asia Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.Southeast Asia Biologics Contract Development Market By End User (2017-2022)
9.3.5. Rest of Asia-Pacific
9.3.5.1.Rest of Asia-Pacific Biologics Contract Development Market and Growth Rate (2017-2022)
9.3.5.2.Rest of Asia-Pacific Biologics Contract Development Market By Source (2017-2022)
9.3.5.2.Rest of Asia-Pacific Biologics Contract Development Market By Product (2017-2022)
9.3.5.2.Rest of Asia-Pacific Biologics Contract Development Market By End User (2017-2022)
6.3. South America
10.3.1. South America Biologics Contract Development Market and Growth Rate (2017-2022))
10.3.2. South America Biologics Contract Development Market By Source (2017-2022)
10.3.2. South America Biologics Contract Development Market By Product (2017-2022)
10.3.2. South America Biologics Contract Development Market By End User (2017-2022)
10.3.4. South America Biologics Contract Development Market By Country (2017-2022)
10.3.5. Brazil
10.3.5.1.Brazil Biologics Contract Development Market and Growth Rate (2017-2022)
10.3.5.2.Brazil Biologics Contract Development Market By Source (2017-2022)
10.3.5.2.Brazil Biologics Contract Development Market By Product (2017-2022)
10.3.5.2.Brazil Biologics Contract Development Market By End User (2017-2022)
10.3.5. Mexico
10.3.5.1.Mexico Biologics Contract Development Market and Growth Rate (2017-2022)
10.3.5.2.Mexico Biologics Contract Development Market By Source (2017-2022)
10.3.5.2.Mexico Biologics Contract Development Market By Product (2017-2022)
10.3.5.2.Mexico Biologics Contract Development Market By End User (2017-2022)
10.3.5. Columbia
10.3.5.1.Columbia Biologics Contract Development Market and Growth Rate (2017-2022)
10.3.5.2.Columbia Biologics Contract Development Market By Source (2017-2022)
10.3.5.2.Columbia Biologics Contract Development Market By Product (2017-2022)
10.3.5.2.Columbia Biologics Contract Development Market By End User (2017-2022)
10.3.5. Rest of South America
10.3.5.1.Rest of South America Biologics Contract Development Market and Growth Rate (2017-2022)
10.3.5.2.Rest of South America Biologics Contract Development Market By Source (2017-2022)
10.3.5.2.Rest of South America Biologics Contract Development Market By Product (2017-2022)
10.3.5.2.Rest of South America Biologics Contract Development Market By End User (2017-2022)
6.3. Middle East and Africa
11.3.1. Middle East and Africa Biologics Contract Development Market and Growth Rate (2017-2022))
11.3.2. Middle East and Africa Biologics Contract Development Market By Source (2017-2022)
11.3.2. Middle East and Africa Biologics Contract Development Market By Product (2017-2022)
11.3.2. Middle East and Africa Biologics Contract Development Market By End User (2017-2022)
11.3.4. Middle East and Africa Biologics Contract Development Market By Country (2017-2022)
11.3.5. Saudi Arabia
11.3.5.1.Saudi Arabia Biologics Contract Development Market and Growth Rate (2017-2022)
11.3.5.2.Saudi Arabia Biologics Contract Development Market By Source (2017-2022)
11.3.5.2.Saudi Arabia Biologics Contract Development Market By Product (2017-2022)
11.3.5.2.Saudi Arabia Biologics Contract Development Market By End User (2017-2022)
11.3.5. United Arab Emirates
11.3.5.1.United Arab Emirates Biologics Contract Development Market and Growth Rate (2017-2022)
11.3.5.2.United Arab Emirates Biologics Contract Development Market By Source (2017-2022)
11.3.5.2.United Arab Emirates Biologics Contract Development Market By Product (2017-2022)
11.3.5.2.United Arab Emirates Biologics Contract Development Market By End User (2017-2022)
11.3.5. South Africa
11.3.5.1.South Africa Biologics Contract Development Market and Growth Rate (2017-2022)
11.3.5.2.South Africa Biologics Contract Development Market By Source (2017-2022)
11.3.5.2.South Africa Biologics Contract Development Market By Product (2017-2022)
11.3.5.2.South Africa Biologics Contract Development Market By End User (2017-2022)
11.3.5. Rest of Middle East and Africa
11.3.5.1.Rest of Middle East and Africa Biologics Contract Development Market and Growth Rate (2017-2022)
11.3.5.2.Rest of Middle East and Africa Biologics Contract Development Market By Source (2017-2022)
11.3.5.2.Rest of Middle East and Africa Biologics Contract Development Market By Product (2017-2022)
11.3.5.2.Rest of Middle East and Africa Biologics Contract Development Market By End User (2017-2022)
7. Company Profiles
7.1. WuXi Biologics
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Abzena Ltd.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Fujifilm Diosynth Biotechnologies
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. KBI Biopharma
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. AGC Biologics
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. LakePharma
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Genscript Biotech Corporation
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bionova Scientific
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. SE Thermo Fisher (Patheon)
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Boehringer Ingelheim BioXcellence
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. STC Biologics, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|